Caribou Biosciences Inc (CRBU)

Caribou Biosciences Inc (CRBU) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $50.4M; returns 1 day -4.9%, 1 week +13.4%, 1 year -78.7%.

Caribou Biosciences Inc. is a clinical-stage biopharmaceutical company leveraging its proprietary CRISPR-Cas gene-editing platform, specifically the chRDNA (CRISPR hybrid RNA-DNA) technology, to develop transformative genome-edited allogeneic, or 'off-the-shelf,' cell therapies for devastating human diseases.

Groups CRBU belongs to

• Biotechnology
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Oncology
• Gene Therapy
• Immunotherapy
• Precision Medicine
• Life Sciences
• Fast Track Designation
• Hematologic Malignancies
• Clinical Stage

CRBU financial model: income statement, cash flow and balance sheet